Literature DB >> 17541922

PLA nano- and microparticles for drug delivery: an overview of the methods of preparation.

Verónica Lassalle1, María Luján Ferreira.   

Abstract

The controlled release of medicaments remains the most convenient way of drug delivery. Therefore, a wide variety of reports can be found in the open literature dealing with drug delivery systems. In particular, the use of nano- and microparticles devices has received special attention during the past two decades. PLA and its copolymers with GA and/or PEG appear as the preferred substrates to fabricate these devices. The methods of fabrication of these particles will be reviewed in this article, describing in detail the experimental variables associated with each one with regard to the influence of them on the performance of the particles as drug carriers. An analysis of the relationship between the method of preparation and the kind of drug to encapsulate is also included. Furthermore, certain issues involved in the addition of other monomeric substrates than lactic acid to the particles formulation as well as novel devices, other than nano- and microparticles, will be discussed in the present work considering the published literature available.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17541922     DOI: 10.1002/mabi.200700022

Source DB:  PubMed          Journal:  Macromol Biosci        ISSN: 1616-5187            Impact factor:   4.979


  38 in total

1.  Fabrication of novel PLA/CDHA bionanocomposite fibers for tissue engineering applications via electrospinning.

Authors:  Huan Zhou; Ahmed H Touny; Sarit B Bhaduri
Journal:  J Mater Sci Mater Med       Date:  2011-03-24       Impact factor: 3.896

2.  Characterization of the TDP-D-ravidosamine biosynthetic pathway: one-pot enzymatic synthesis of TDP-D-ravidosamine from thymidine-5-phosphate and glucose-1-phosphate.

Authors:  Madan K Kharel; Hui Lian; Jürgen Rohr
Journal:  Org Biomol Chem       Date:  2011-01-24       Impact factor: 3.876

3.  Biodegradable DNA-Brush Block Copolymer Spherical Nucleic Acids Enable Transfection Agent-Free Intracellular Gene Regulation.

Authors:  Chuan Zhang; Liangliang Hao; Colin M Calabrese; Yu Zhou; Chung Hang J Choi; Hang Xing; Chad A Mirkin
Journal:  Small       Date:  2015-08-21       Impact factor: 13.281

4.  Controlled release of a heterogeneous human placental matrix from PLGA microparticles to modulate angiogenesis.

Authors:  Sarah Tonello; Marc C Moore; Blanka Sharma; Jon Dobson; Peter S McFetridge
Journal:  Drug Deliv Transl Res       Date:  2016-04       Impact factor: 4.617

5.  Preparation of particulate polymeric therapeutics for medical applications.

Authors:  Jia Zhuang; Ronnie H Fang; Liangfang Zhang
Journal:  Small Methods       Date:  2017-07-25

6.  Cloning and characterization of the ravidomycin and chrysomycin biosynthetic gene clusters.

Authors:  Madan K Kharel; S Eric Nybo; Micah D Shepherd; Jürgen Rohr
Journal:  Chembiochem       Date:  2010-03-01       Impact factor: 3.164

Review 7.  Innovative strategies for co-delivering antigens and CpG oligonucleotides.

Authors:  Yogita Krishnamachari; Aliasger K Salem
Journal:  Adv Drug Deliv Rev       Date:  2009-01-19       Impact factor: 15.470

8.  Investigation of polylactic acid (PLA) nanoparticles as drug delivery systems for local dermatotherapy.

Authors:  Fiorenza Rancan; Dimitrios Papakostas; Sabrina Hadam; Steffen Hackbarth; Thierry Delair; Charlotte Primard; Bernard Verrier; Wolfram Sterry; Ulrike Blume-Peytavi; Annika Vogt
Journal:  Pharm Res       Date:  2009-06-17       Impact factor: 4.200

9.  Ocular biocompatibility and structural integrity of micro- and nanostructured poly(caprolactone) films.

Authors:  Daniel A Bernards; Robert B Bhisitkul; Paula Wynn; Mark R Steedman; On-Tat Lee; Fergus Wong; Somanus Thoongsuwan; Tejal A Desai
Journal:  J Ocul Pharmacol Ther       Date:  2013-02-07       Impact factor: 2.671

Review 10.  PLA micro- and nano-particles.

Authors:  Byung Kook Lee; Yeonhee Yun; Kinam Park
Journal:  Adv Drug Deliv Rev       Date:  2016-06-01       Impact factor: 15.470

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.